Kaplan-Meier survival curve showed that IDH1/2 gene and TERT promoter mutation were significantly different from those of wild-type patients, again, it is suggested that IDH1/2 gene and TERT promoter mutations are related to the survival of patients with glioma. This evidence concerns the gene IDH1 and central nervous system cancer.